(Press-News.org) (WASHINGTON – August 6, 2025) – Most patients with high-risk myelodysplastic syndromes (MDS) do not receive guideline-recommended treatment with hypomethylating agents (HMAs), according to results published in Blood Neoplasia. The findings suggest that underuse of these drugs may help explain why MDS outcomes have not improved over the past two decades since these life-extending medications became available.
The study is the largest analysis of MDS treatment patterns in the United States to date and the most comprehensive study of real-world use of HMAs, which are highly effective in improving outcomes. HMAs are the best available treatment option for the majority of older people with high-risk disease who cannot get a curative bone marrow transplant. According to the study findings, about half of patients who should be started on an HMA are not receiving these drugs, and even among those who do start treatment, many do not complete the recommended therapy. The results also showed that women and non-white patients were significantly less likely to receive the treatment than white males.
“The disparities we found based on gender, race, and ethnicity were really striking,” said the study’s lead author, Sudipto Mukherjee, MD, PhD, MPH, a physician in the department of hematology and medical oncology at Cleveland Clinic. “Given the absence of newly approved therapies over the last two decades, the most impactful way to improve outcomes in newly diagnosed high-risk MDS requires that we do better with the available therapies. Making changes with these therapies and how they are given (that is, when to treat and how to treat) is a key intervention that can have a huge impact.”
MDS, a group of blood cancers in which the bone marrow does not produce enough healthy blood cells, causes debilitating fatigue and increased susceptibility to infections and bleeding. Without treatment, MDS can progress to acute myeloid leukemia. MDS is most common in adults over the age of 70, most of whom cannot get a bone marrow transplant – the only known cure for MDS – due to frailty, comorbidities, or cost.
HMAs modify the genes involved in blood formation in a way that boosts the production of healthy blood cells and slows the progression of MDS. Although these drugs do not cure the disease, clinical trials have shown that they help patients live longer and improve quality of life. However, real-world outcomes have shown little improvement since the U.S. Food and Drug Administration approved two HMAs, azacitidine and decitabine, for high-risk MDS about 20 years ago.
The researchers analyzed Medicare claims data from more than 49,000 U.S. adults to assess which patients received HMAs and whether the drugs were being administered according to guidelines. They assessed clinical factors such as blood counts, transfusions, frailty, and comorbidities, as well as demographic factors such as population density, neighborhood education and poverty levels, and the concentration of physicians and specialists where patients live.
According to the findings, just 16% of newly diagnosed patients with MDS on Medicare received HMAs during the period analyzed (2011-2014). This is about half of the estimated 30-40% of patients who fall into the high-risk category at the time of diagnosis for which HMAs are recommended. People who were older than 85, female, or non-white were significantly less likely to start HMA treatment. Although men and women are diagnosed with MDS at roughly the same rate, the study found women were 19% less likely to start HMAs. Black patients were 30% less likely to start HMAs, and patients of other races were 22% less likely to start HMAs compared to white patients.
Researchers suggested that the lower rate of HMA uptake among people over age 85 may be explained by a tendency for older patients to decline treatment. However, they could not identify any obvious reason why women or non-white patients would be less likely to receive the treatment, suggesting that implicit bias may be a factor.
The dosing and duration of treatment strongly influence HMA outcomes, with the best response to treatment typically achieved after four to six one-month cycles. However, the study revealed that most patients who received HMAs did not complete the treatment as recommended. Over one-third of patients discontinued the treatment by the end of the fourth cycle, and half discontinued by the end of the sixth cycle. Fewer than half (30-40%) received the full guideline-directed dose of their drug in each of the first four cycles.
“If you are not even treating the patients for the recommended duration of time, you will not see a response,” said Dr. Mukherjee. “When starting these treatments, blood counts and transfusion needs may initially get worse before they improve, and you have to plow through it. That is not the time to discontinue, but that is what the data is saying.”
It is normal for patients’ blood cell counts to decrease in the first few cycles of HMA treatment, which can lead to increased fatigue and a greater need for blood transfusions. Based on the data, Dr. Mukherjee suggested that doctors and patients may be too quick to skip doses or stop treatment in response to these effects. While this can be understandable in cases where patients have less support, or access to care, or are in poorer health overall, failing to deliver the full course of treatment as recommended undermines patients’ ability to fully benefit from these medications.
One way to address this gap could be for community health clinics to partner with larger tertiary care centers to guide HMA treatment, Dr. Mukherjee suggested. For example, patients could visit a hospital with more expertise in HMA treatment for a one-time consultation to formulate a treatment plan, and then return to their local community clinic where doctors would follow through on that recommended course of treatment, referring back to the tertiary care center as needed for guidance on handling side effects or altering the dosage.
As the study was a retrospective analysis based on Medicare claims data, the researchers noted that they did not have access to data on disease markers necessary to comprehensively assess the appropriateness of the decision of whether or not to start HMA treatment in all patients, nor did the data specify why HMA treatment was stopped early in each case. Despite these limitations, using Medicare claims data provided a large, nationally representative study cohort in older adults, a demographic with the highest prevalence of MDS.
###
Blood Neoplasia (www.bloodneoplasia.org) is an online only, open access journal of the American Society of Hematology (www.hematology.org), the world’s largest professional society concerned with the causes and treatment of blood disorders.
Contact:
Claire Whetzel, 202-629-5085
cwhetzel@hematology.org
END
Effective therapy for MDS is vastly underused, especially in female and non-white patients
Over half of eligible patients do not receive recommended therapies or complete the full course of treatment; white males are most likely to get the right treatment at the right dose
2025-08-06
ELSE PRESS RELEASES FROM THIS DATE:
Genetic rescue of endangered species may risk bad mutations slipping through
2025-08-06
COLUMBUS, Ohio – The established conservation practice of relocating animals from large, genetically diverse populations to small communities of inbred endangered species may risk introducing more damaging than beneficial gene variants into the threatened group, a new study suggests.
Analysis of genomes of Eastern massasauga rattlesnakes showed that, by the numbers, more deleterious than adaptation-enabling mutations were present in the more genetically diverse donor animals selected in a hypothetical scenario to join a small, isolated population.
Because donor relocation, known as ...
480 macrofungal species discovered in southeast Xizang, China: 8 new species, 115 edible, and 53 poisonous fungi
2025-08-06
The research group of fungal diversity and molecular evolution at Kunming Institute of Botany, Chinese Academy of Sciences conducted in-depth research on more than 1,600 samples of macrofungi collected from 2019 to 2024 by means of species identification combining morphology and molecular systematics. The results showed that there were 480 species of macrofungi in this area, covering 7 classes, 17 orders, 67 families, and 158 genera of Ascomycota and Basidiomycota, and 8 new species were described.
Fungal diversity patterns revealed taxonomic dominance at both family and genus levels. Among the 67 documented families, 15 were dominant (≥10 species each), collectively representing ...
New study on hope among U.S. youth reveals key to safer schools this fall
2025-08-06
Given the current youth mental health crisis in the United States, many adolescents report experiencing low levels of hope – a longstanding concern that is even more pressing as the new school year begins. Substantial research over decades has established that higher levels of hope are linked with greater academic achievement, as well as improved emotional and physical health.
Now, a new study shows that hope does even more: it acts as a powerful protective force in the lives of children, helping to reduce both bullying and cyberbullying.
The study by Florida Atlantic University, in collaboration with the University of Wisconsin–Eau Claire, surveyed a nationally representative ...
AI chatbots can run with medical misinformation, study finds, highlighting the need for stronger safeguards
2025-08-06
New York, NY [August 6, 2025] — A new study by researchers at the Icahn School of Medicine at Mount Sinai finds that widely used AI chatbots are highly vulnerable to repeating and elaborating on false medical information, revealing a critical need for stronger safeguards before these tools can be trusted in health care.
The researchers also demonstrated that a simple built-in warning prompt can meaningfully reduce that risk, offering a practical path forward as the technology rapidly evolves. Their findings were detailed in the August 2 online issue of Communications Medicine ...
Nanoparticles for rheumatoid arthritis prevention, flare control
2025-08-06
As a chronic condition, rheumatoid arthritis (RA) can’t be cured, so treatment focuses on managing the disease and controlling its progression. Although current treatments help control RA symptoms in most people, they cannot prevent the onset of RA or painful flare-ups. Now, researchers publishing in ACS Central Science have developed nanoparticles that could slow disease progression and reduce flare severity, based on results from tests with human blood and mice models with RA-like disease.
For a person diagnosed with RA, their immune system attacks tissue that makes up the joints, causing inflammation, swelling and pain. ...
Small-world networks can mitigate ESG controversies for multinationals, suggests new study
2025-08-06
Multinational enterprises (MNEs) can negate supplier-induced environmental, social and governance (ESG) controversies by setting up ‘small-world’ networks, according to new research co-authored by Bayes Business School.
Globalising supply chains has become a dominant strategy for MNEs. Benefits include lower costs of labour and distribution, and greater scope for innovation.
However, long-distance operations also carry associated risks. Contrasting ethical standards of suppliers in different areas of the world can lead to ...
Yonsei University researchers directly measure quantum metric tensor in real material
2025-08-06
Quantum distance refers to a measure of quantum mechanical similarity between two quantum states. A quantum distance of one means that the two quantum states are the same, whereas a quantum distance of zero implies that they are exactly the opposite. Physicists introduced this concept in the realm of theoretical science a long time ago, but its importance has been increasingly recognized in the field of physics only in recent times.
In the last few years, many experimental physicists have tried to measure the quantum distance of electrons ...
TEER associated with improved survival in the elderly patients with AFMR
2025-08-06
The mitral valve controls blood flow between the heart’s left atrium and ventricle. When structural changes affect the atrium or valve, it may not close fully—causing blood to leak backwards, a condition known as atrial functional mitral regurgitation (AFMR). Common in frail or elderly patients, AFMR often leads to heart failure, and standard surgery is typically too risky due to other health issues.
Transcatheter edge-to-edge repair (TEER), a minimally invasive surgery, has emerged as a low-risk treatment option for various ...
Excessive screen time among youth may pose heart health risks
2025-08-06
Research Highlights:
Increased time on electronic devices or watching TV among children and young adults was associated with higher cardiometabolic disease risk, such as high blood pressure, high cholesterol and insulin resistance, based on data from over 1,000 study participants in Denmark.
The link between screen time and cardiometabolic risks was strongest among youth who slept fewer hours, suggesting that screen use may harm health by “stealing” time from sleep, researchers said.
Researchers said the findings underscore the ...
Pure quantum state without the need for cooling
2025-08-06
Three nano glass spheres cling to one another. They form a tower-like cluster, similar to when you pile three scoops of ice cream on top of one another – only much smaller. The diameter of the nano cluster is ten times smaller than that of a human hair. With the help of an optical device and laser beams, researchers at ETH Zurich have succeeded in keeping such objects almost completely motionless in levitation. This is significant when it comes to the future development of quantum sensors, which, together with quantum computers, constitute the most promising applications of quantum research.
As part of their levitation ...
LAST 30 PRESS RELEASES:
Virtual reality shows promise in easing stress for cardiac patients, UCLA Health study finds
MBARI researchers deploy new imaging system to study the movement of deep-sea octopus
Scrambled RNA nudges millions of people towards type-2 diabetes
Big heart, acute senses key to explosive radiation of early fishes
Getting sticky: The highest-performing underwater adhesive hydrogel polymer
The health impact of wildfires in Los Angeles County and Maui
Replacing brain immune cells in mice slows neurodegeneration in Stanford Medicine study
Early heartbeats direct the heart’s own development and growth
Changes to El Niño occurrence causing widespread tropical insect and spider declines
Nanophotonics: An ultrafast light switch
Human instruction with artificial intelligence guidance provided best results in neurosurgical training
IHME’s 2025 Roux Prize awarded to rural health equity advocate – recognized for advancing access to oral health care in Nigeria
Archaeologists find oldest evidence of humans on ‘Hobbit’s’ island neighbor – who they were remains a mystery
Novel microwave dielectric ceramics enable high-performance 5G/6G communication devices
Revealed: New vaccine target to block malaria transmission
Air purifiers may reduce heart risks for people exposed to traffic pollution
Effective therapy for MDS is vastly underused, especially in female and non-white patients
Genetic rescue of endangered species may risk bad mutations slipping through
480 macrofungal species discovered in southeast Xizang, China: 8 new species, 115 edible, and 53 poisonous fungi
New study on hope among U.S. youth reveals key to safer schools this fall
AI chatbots can run with medical misinformation, study finds, highlighting the need for stronger safeguards
Nanoparticles for rheumatoid arthritis prevention, flare control
Small-world networks can mitigate ESG controversies for multinationals, suggests new study
Yonsei University researchers directly measure quantum metric tensor in real material
TEER associated with improved survival in the elderly patients with AFMR
Excessive screen time among youth may pose heart health risks
Pure quantum state without the need for cooling
NHS Active 10 walking tracker users are more active after using the app
Ultraviolet light reveals the aftermath of rare star collision
Growing shade trees can cut chocolate’s environmental impact
[Press-News.org] Effective therapy for MDS is vastly underused, especially in female and non-white patientsOver half of eligible patients do not receive recommended therapies or complete the full course of treatment; white males are most likely to get the right treatment at the right dose